Cyclopentobarbital: Difference between revisions
Appearance
Content deleted Content added
m Stub sorting and placement of stub template(s): sedative-stub. See approval. Report errors and suggestions at User talk:PotatoBot. |
Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject_Pharmacology|er |
||
Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 399738699 |
||
| IUPAC_name = 5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-<br>diazinane-2,4,6-trione |
| IUPAC_name = 5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-<br>diazinane-2,4,6-trione |
||
| image = Cyclopal.svg |
| image = Cyclopal.svg |
||
Line 29: | Line 29: | ||
| ATC_suffix = |
| ATC_suffix = |
||
| PubChem = 6454 |
| PubChem = 6454 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
Revision as of 18:28, 10 September 2011
![]() | |
Clinical data | |
---|---|
Other names | Allylpental, Cyclopental, Dormisan, 5-Allyl-5-Δ2-Cyclopentenyl Barbituric Acid |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.891 |
Chemical and physical data | |
Formula | C12H14N2O3 |
Molar mass | 234.251 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cyclopal (Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine.[1] Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
References
- ^ Vander Brook MJ, Cartland GF. A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal). Journal of Pharmacology And Experimental Therapeutics, 1944, 80(2): 119-125